Senior insider sale
SVP, GC & Corporate Secretary at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$3.99M
103.67K shares
REED ELIZABETH E plans to sell 103.67K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $3.99M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Performance Restricted Stock Unit Vesting
Compensation
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/4/2026 | Performance Restricted Stock Unit Vesting Compensation | 2.17K | — |
| Total | 2.17K | ||
Completed
Units to sell
20K
Market value
$900.0K
Units to sell
6.79K
Market value
$283.8K
Units to sell
37.50K
Market value
$1.54M
Units to sell
7.21K
Market value
$302.5K
Units to sell
10K
Market value
$300.0K
Units to sell
10K
Market value
$280.9K
Units to sell
10K
Market value
$278.3K
Planned — Approximate Date
Units to sell
2.17K
Market value
$101.4K
Units
103.67K
Value
$3.99M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/4/2026 | 20K | $900.0K | — | Completed |
4/15/2026 | 6.79K | $283.8K | — | Completed |
4/14/2026 | 37.50K | $1.54M | — | Completed |
4/14/2026 | 7.21K | $302.5K | — | Completed |
4/1/2026 | 10K | $300.0K | — | Completed |
3/16/2026 | 10K | $280.9K | — | Completed |
2/17/2026 | 10K | $278.3K | — | Completed |
| Planned — Approximate Date | ||||
5/5/2026 | 2.17K | $101.4K | NASDAQ | Planned |
| Total | 103.67K | $3.99M | ||